BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ritsinger V, Malmberg K, Mårtensson A, Rydén L, Wedel H, Norhammar A. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial. Lancet Diabetes Endocrinol 2014;2:627-33. [PMID: 24831989 DOI: 10.1016/S2213-8587(14)70088-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 20] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Lysy Z, Fung K, Giannakeas V, Fischer HD, Bell CM, Lipscombe LL. The Association Between Insulin Initiation and Adverse Outcomes After Hospital Discharge in Older Adults: a Population-Based Cohort Study. J Gen Intern Med 2019;34:575-82. [PMID: 30756304 DOI: 10.1007/s11606-019-04849-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ye M, Choy M, Liu X, Huang P, Wu Y, Dong Y, Zhu W, Liu C. Associations of BMI with mortality in HFpEF patients with concomitant diabetes with insulin versus non-insulin treatment. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109805] [Reference Citation Analysis]
3 Fiorentino TV, Sesti G. Lessons learned from cardiovascular outcome clinical trials with dipeptidyl peptidase 4 (DPP-4) inhibitors. Endocrine 2016;53:373-80. [PMID: 26611248 DOI: 10.1007/s12020-015-0811-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
4 Dharma S, Mahavira A, Haryono N, Sukmawan R, Dakota I, Siswanto BB, Rao SV. Association of Hyperglycemia and Final TIMI Flow with One-Year Mortality of Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI. Int J Angiol 2019;28:182-7. [PMID: 31452586 DOI: 10.1055/s-0039-1691811] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Russian Society of Cardiology (. 2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction. Russ J Cardiol 2020;25:4103. [DOI: 10.15829/29/1560-4071-2020-4103] [Cited by in Crossref: 49] [Cited by in F6Publishing: 6] [Article Influence: 24.5] [Reference Citation Analysis]
6 Dandona P, Chaudhuri A. Diabetes: Glycaemia and insulin after acute myocardial infarction. Nat Rev Endocrinol 2014;10:448-50. [PMID: 24981456 DOI: 10.1038/nrendo.2014.101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
7 Narcisse DI, Katzenberger DR, Gutierrez JA. Contemporary Medical Therapies for Patients with Peripheral Artery Disease and Concomitant Type 2 Diabetes Mellitus: a Review of Current Evidence. Curr Cardiol Rep 2022. [PMID: 35201560 DOI: 10.1007/s11886-022-01677-6] [Reference Citation Analysis]
8 . Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD). Revista Española de Cardiología 2020;73:404.e1-404.e59. [DOI: 10.1016/j.recesp.2019.11.024] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ke JF, Wang JW, Zhang ZH, Chen MY, Lu JX, Li LX. Insulin Therapy Is Associated With an Increased Risk of Carotid Plaque in Type 2 Diabetes: A Real-World Study. Front Cardiovasc Med 2021;8:599545. [PMID: 33598483 DOI: 10.3389/fcvm.2021.599545] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Ahmad S, Ahmad RA, Qureshi BA, Baig MAR. Myocardial protection with Glucose-Insulin-Potassium infusion during adult cardiac surgery. Pak J Med Sci 2017;33:325-9. [PMID: 28523031 DOI: 10.12669/pjms.332.12414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
11 Liu J, Wang S, Cui C, Cai H, Sun R, Pan W, Fang S, Yu B. The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction. Cardiovasc Diabetol 2020;19:109. [PMID: 32641042 DOI: 10.1186/s12933-020-01074-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Sasso FC, Rinaldi L, Lascar N, Marrone A, Pafundi PC, Adinolfi LE, Marfella R. Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes. J Diabetes Res 2018;2018:3106056. [PMID: 30402502 DOI: 10.1155/2018/3106056] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 13.0] [Reference Citation Analysis]
13 Shamshirgaran SM, Ataei J, Malek A, Iranparvar-Alamdari M, Aminisani N. Quality of sleep and its determinants among people with type 2 diabetes mellitus in Northwest of Iran. World J Diabetes 2017; 8(7): 358-364 [PMID: 28751959 DOI: 10.4239/wjd.v8.i7.358] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
14 Bellis A, Di Gioia G, Mauro C, Mancusi C, Barbato E, Izzo R, Trimarco B, Morisco C. Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy. J Clin Med 2021;10:2968. [PMID: 34279451 DOI: 10.3390/jcm10132968] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Pechlivani N, Ajjan RA. Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets. Front Cardiovasc Med 2018;5:1. [PMID: 29404341 DOI: 10.3389/fcvm.2018.00001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
16 Bellis A, Mauro C, Barbato E, Ceriello A, Cittadini A, Morisco C. Stress-Induced Hyperglycaemia in Non-Diabetic Patients with Acute Coronary Syndrome: From Molecular Mechanisms to New Therapeutic Perspectives. Int J Mol Sci 2021;22:E775. [PMID: 33466656 DOI: 10.3390/ijms22020775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Mannucci E, Giannini S, Dicembrini I. Cardiovascular effects of basal insulins. Drug Healthc Patient Saf 2015;7:113-20. [PMID: 26203281 DOI: 10.2147/DHPS.S43300] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
18 Everett CC, Reynolds C, Fernandez C, Stocken DD, Sharples LD, Sathyapalan T, Heller S, Storey RF, Ajjan RA. Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction. Diab Vasc Dis Res 2020;17:1479164120957934. [PMID: 33081502 DOI: 10.1177/1479164120957934] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Hanefeld M, Fleischmann H, Siegmund T, Seufert J. Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update. Diabetes Ther 2020;11:1645-66. [PMID: 32564335 DOI: 10.1007/s13300-020-00855-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
20 Avogaro A, Fadini GP, Sesti G, Bonora E, Del Prato S. Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice. Cardiovasc Diabetol 2016;15:111. [PMID: 27514514 DOI: 10.1186/s12933-016-0431-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]